BPC157 has been studied in healthy adults and found to be well-tolerated with no adverse effects on cardiac, hepatic, renal, thyroid, or glycemic biomarkers
C5aR1 knockdown decreases METTL3-mediated m6A modification of GPX4 To investigate the regulation of GPX4 expression by C5aR1 in GBM cells, the GPX4 mRNA level was measured using RT-qPCR
Unlike single-pathway compounds, AHK-Cu enables researchers to investigate how mineral-peptide complexes influence multiple biological systems simultaneously, including cellular repair, follicular activity, and gene regulation
Even more concerning are findings that MASLD, as an independent factor, increases the risk of certain extrahepatic tumors
I think BPC-157 is an expensive placebo being shilled for cash on the back of anecdotes and vibes